Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O <sup>6</sup> -Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET)

Despite the fact that the primary end point was not reached, ALKY has clinical activity in patients with dMGMT-NETs.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2024-11-25
DOI
https://doi.org/10.1200/jco.23.02724
Citations
11
Primary Topic
Neuroendocrine Tumor Research Advances
Type
article
Field-Weighted Citation Impact
4.25
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O 6 -Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET)

Thomas Walter, Olivia Hentic, Maxime Bonjour, Caroline Pétorin et al.
11 citations
Journal of Clinical Oncology
Neuroendocrine Tumor Research Advances
4.25
article

Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O 6 -Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET)

Thomas Walter, Olivia Hentic, Maxime Bonjour, Caroline Pétorin, Marc Barritault, Benjamin Gibert, Thomas Aparicio, Jean‐Yves Scoazec, Vincent Hautefeuille, Delphine Poncet, Christine Do Cao, Élisabeth Gaye, Marine Perrier, Laura Gérard, Julien Hadoux, Patricia Niccoli, Thierry Lecomte, Léa Saban-Roche, Rosine Guimbaud, Alice Durand, Valérie Hervieu, Mathieu Baconnier
article en
11 citations

Abstract

Despite the fact that the primary end point was not reached, ALKY has clinical activity in patients with dMGMT-NETs.

Journal of Clinical OncologyVol. 43(8)
Université Claude Bernard Lyon 1 (FR), Université de Tours (FR), Centre National de la Recherche Scientifique (FR), Inserm (FR), Université Paris Cité (FR), Hôpital Beaujon (FR), Institut Gustave Roussy (FR), Institut Pprime (FR), Centre Hospitalier Universitaire de Lille (FR), Centre Hospitalier Universitaire de Toulouse (FR), Lille’s Cardiology Hospital (FR), Centre Hospitalier Universitaire Amiens-Picardie (FR), Assistance Publique – Hôpitaux de Paris (FR), Hospices Civils de Lyon (FR), Centre Hospitalier Universitaire de Reims (FR), Institute Cancer De La Loire Lucien Neuwirth (FR), Centre de Recherche en Cancérologie de Lyon (FR), Hôpital Robert-Debré (FR), Centre Hospitalier Universitaire de Clermont-Ferrand (FR), Centre Oscar Lambret (FR), Centre Hospitalier Annecy Genevois (FR), Hôpital Saint-Louis (FR), Institut Paoli-Calmettes (FR), Université de Reims Champagne-Ardenne (FR)
Good health and well-being
Openalex Percentile: Top 5%
Neuroendocrine Tumor Research Advances
4.25
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.